Improvements in BAC fingerprinting and end sequencing

BAC 指纹识别和末端测序的改进

基本信息

项目摘要

DESCRIPTION (provided by applicant): The work described in the Research Plan will have two important consequences. First, it will result in more efficient, less expensive methods for the production of accurate BAC fingerprint maps and end sequences. Second, it will result in the generation of at least 2,800,000 fingerprinted clones, assembled into fingerprint maps for 14 large (e.g. mammalian) genomes. We will undertake our proposed software and "wet lab" technology development exercises in the context of a production fingerprint mapping effort, using methods we established to generate the maps over the three years of the proposal. Software development will include automated lane tracking of fingerprinting gels, improving our automated restriction fragment identification software (BandLeader), and modification of it so that it produces probability-based measures of restriction fragment quality. These "quality values", produced for each restriction fragment, will be exploited by new software we are developing to correctly and automatically order clones within contigs. Automatic selection of clone tiling sets will also be developed. Fingerprint maps will be made available for download on our website in FPC format and for viewing using our Internet Contig Explorer (ICE) software. We will provide lists of tiling set clones to the sequencing centers to support their sequencing goals. BAC-end sequencing technology development will emphasize experiments aimed at reduction in volume of expensive sequencing reagents, less expensive DNA purification and reduced use of expensive plasticware. We will place special emphasis on improving capillary array electrophoresis and low volume thermocycling methods as these may impact both costs of sequencing reagents and DNA purification. Finally, we will evaluate commercially available BAC DNA purification reagents for performance in both end sequencing and fingerprinting. If the performance and cost of the reagents are favorable, we will undertake experiments to automate one or more of the commercially available kits. Should this be successful, we will integrate the new protocols and processes into our production fingerprinting group.
描述(由申请人提供):研究计划中描述的工作将产生两个重要的后果。首先,它将导致更有效,更便宜的方法来生产准确的BAC指纹图和最终序列。其次,这将导致至少生成2,800,000个指纹克隆,并将14个大(例如哺乳动物)基因组的指纹图组装成指纹图。我们将在生产指纹映射工作的背景下,使用我们建立的方法来生成图中的三年中,我们将在生产指纹映射工作的背景下进行提出的软件和“湿实验室”技术开发练习。软件开发将包括对指纹凝胶的自动车道跟踪,改善我们的自动限制片段识别软件(BandLeader),以及对其进行修改,从而产生基于概率的限制片段质量的测量。这些针对每个限制片段产生的“质量值”将被我们开发的新软件利用,以正确,自动在重叠群中订购克隆。也将开发自动选择克隆瓷砖集。指纹图将以FPC格式在我们的网站上下载,并使用我们的Internet Contig Explorer(ICE)软件进行查看。我们将向测序中心提供平铺设定的克隆列表,以支持其测序目标。 BAC-END测序技术开发将强调旨在减少昂贵的测序试剂量,较便宜的DNA纯化和减少昂贵塑料软件的使用的实验。我们将特别强调改善毛细管阵列电泳和低体积热环节方法,因为这些方法可能会影响测序试剂的成本和DNA纯化。最后,我们将评估在末端测序和指纹识别中性能的市售BAC DNA纯化试剂。如果试剂的性能和成本是有利的,我们将进行实验,以使一个或多个市售套件自动化。如果这是成功的,我们将将新的协议和流程整合到我们的生产指纹组中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

暂无数据

数据更新时间:2024-06-01

Marco A. Marra其他文献

Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 <em>BRAF</em> Mutant Colorectal Cancer
  • DOI:
    10.1016/j.clcc.2020.02.001
    10.1016/j.clcc.2020.02.001
  • 发表时间:
    2020-06-01
    2020-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shehara Mendis;Miguel Alcaide;James T. Topham;Benny Johnson;Ryan D. Morin;Jenny Chu;Ian Bosdet;Scott Kopetz;Aly Karsan;Sharlene Gill;Janessa Laskin;Steven J.M. Jones;Marco A. Marra;David F. Schaeffer;Daniel J. Renouf;Jonathan M. Loree
    Shehara Mendis;Miguel Alcaide;James T. Topham;Benny Johnson;Ryan D. Morin;Jenny Chu;Ian Bosdet;Scott Kopetz;Aly Karsan;Sharlene Gill;Janessa Laskin;Steven J.M. Jones;Marco A. Marra;David F. Schaeffer;Daniel J. Renouf;Jonathan M. Loree
  • 通讯作者:
    Jonathan M. Loree
    Jonathan M. Loree
Recurrent Copy Number Alterations Contribute to a Unique Genetic Landscape in Relapsed-Refractory DLBCL
  • DOI:
    10.1182/blood-2022-169623
    10.1182/blood-2022-169623
  • 发表时间:
    2022-11-15
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Christopher K Rushton;Ryan N Rys;Elizabeth Chavez;Laura K Hilton;Miguel Alcaide;Kostiantyn Dreval;Matthew Cheung;Manuela Cruz;Krysta M. Coyle;Barbara Meissner;Susana Ben-Neriah;Neil R. Michaud;Scott Daigle;Jordan Davidson;Jasper Wong;Annette E. Hay;Michael D. Jain;Lois E. Shepherd;Marco A. Marra;John Kuruvilla
    Christopher K Rushton;Ryan N Rys;Elizabeth Chavez;Laura K Hilton;Miguel Alcaide;Kostiantyn Dreval;Matthew Cheung;Manuela Cruz;Krysta M. Coyle;Barbara Meissner;Susana Ben-Neriah;Neil R. Michaud;Scott Daigle;Jordan Davidson;Jasper Wong;Annette E. Hay;Michael D. Jain;Lois E. Shepherd;Marco A. Marra;John Kuruvilla
  • 通讯作者:
    John Kuruvilla
    John Kuruvilla
Relapse Timing Is Associated with Distinct Evolutionary Dynamics and Response to Salvage Therapy in DLBCL
  • DOI:
    10.1182/blood-2022-160187
    10.1182/blood-2022-160187
  • 发表时间:
    2022-11-15
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Laura K Hilton;Henry S. Ngu;Brett Collinge;Kostiantyn Dreval;Susana Ben-Neriah;Christopher K Rushton;Jasper Wong;Manuela Cruz;Andrew Roth;Merrill Boyle;Barbara Meissner;Graham W. Slack;Pedro Farinha;Jeffrey W. Craig;Alina S. Gerrie;Ciara L. Freeman;Diego Villa;Kerry J. Savage;Laurie H. Sehn;Marco A. Marra
    Laura K Hilton;Henry S. Ngu;Brett Collinge;Kostiantyn Dreval;Susana Ben-Neriah;Christopher K Rushton;Jasper Wong;Manuela Cruz;Andrew Roth;Merrill Boyle;Barbara Meissner;Graham W. Slack;Pedro Farinha;Jeffrey W. Craig;Alina S. Gerrie;Ciara L. Freeman;Diego Villa;Kerry J. Savage;Laurie H. Sehn;Marco A. Marra
  • 通讯作者:
    Marco A. Marra
    Marco A. Marra
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors
探索接受免疫检查点抑制剂治疗的晚期癌症患者的种系相关性和免疫相关不良事件的风险
  • DOI:
  • 发表时间:
    2024
    2024
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    E. Titmuss;Irene S. Yu;E. Pleasance;L. Williamson;K. Mungall;A. Mungall;D. Renouf;Richard A. Moore;Steven J. M. Jones;Marco A. Marra;J. Laskin;Kerry J Savage
    E. Titmuss;Irene S. Yu;E. Pleasance;L. Williamson;K. Mungall;A. Mungall;D. Renouf;Richard A. Moore;Steven J. M. Jones;Marco A. Marra;J. Laskin;Kerry J Savage
  • 通讯作者:
    Kerry J Savage
    Kerry J Savage
Towards a Unified Genetic Classification System for Diffuse Large B-Cell Lymphoma (DLBCL)
  • DOI:
    10.1182/blood-2022-167043
    10.1182/blood-2022-167043
  • 发表时间:
    2022-11-15
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Kostiantyn Dreval;Laura K Hilton;Krysta M. Coyle;Jasper Wong;Merrill Boyle;Brett Collinge;Manuela Cruz;Barbara Meissner;Christopher K Rushton;Marco A. Marra;David W. Scott;Christian Steidl;Ryan D. Morin
    Kostiantyn Dreval;Laura K Hilton;Krysta M. Coyle;Jasper Wong;Merrill Boyle;Brett Collinge;Manuela Cruz;Barbara Meissner;Christopher K Rushton;Marco A. Marra;David W. Scott;Christian Steidl;Ryan D. Morin
  • 通讯作者:
    Ryan D. Morin
    Ryan D. Morin
共 9 条
  • 1
  • 2
前往

Marco A. Marra的其他基金

Improvements in BAC fingerprinting and end sequencing
BAC 指纹识别和末端测序的改进
  • 批准号:
    6733577
    6733577
  • 财政年份:
    2003
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:
Improvements in BAC fingerprinting and end sequencing
BAC 指纹识别和末端测序的改进
  • 批准号:
    6887347
    6887347
  • 财政年份:
    2003
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:

相似海外基金

Improvements in BAC fingerprinting and end sequencing
BAC 指纹识别和末端测序的改进
  • 批准号:
    6733577
    6733577
  • 财政年份:
    2003
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:
Improvements in BAC fingerprinting and end sequencing
BAC 指纹识别和末端测序的改进
  • 批准号:
    6887347
    6887347
  • 财政年份:
    2003
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:
UW Genome Center Large-scale Sequencing Program
华盛顿大学基因组中心大规模测序计划
  • 批准号:
    6744072
    6744072
  • 财政年份:
    1999
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:
UW Genome Center Large-scale Sequencing Program
华盛顿大学基因组中心大规模测序计划
  • 批准号:
    6881394
    6881394
  • 财政年份:
    1999
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别:
UW Genome Center Large-scale Sequencing Program
华盛顿大学基因组中心大规模测序计划
  • 批准号:
    7208563
    7208563
  • 财政年份:
    1999
  • 资助金额:
    $ 174.69万
    $ 174.69万
  • 项目类别: